36 The cost of a brain tumour: The Economic Case for Urgent Action

Clicks: 14
ID: 326660
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #260 of 286 articles by views in journal of neuro-oncology

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 286 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Introduction Each year over 13,000 people are diagnosed with brain tumours in the UK and 5,400 people lose their lives. Brain tumours have a substantial impact on individual health and on wider society; however, little research has been conducted to estimate the overall burden that brain tumours have on society in the UK. Methods The lifetime burden of illness from brain tumours diagnosed in 2025 was calculated from several sources. There were two categories of impact: (i) financial costs and (ii) health impacts. Financial costs included healthcare costs, income loss, excess welfare spending and additional care requirements (beyond treatment). Inputs were distinguished by adult or child and malignant or non-malignant tumour. The monetary value of health lost was calculated using the societal valuation of £70,000 per quality-adjusted life year (assigned by the Treasury Green Book). Results The burden of illness of brain tumours diagnosed in the UK in 2025 is estimated to be £18.7 billion over those people’s lifetime. This was based on 5,629 high-grade and 6,528 low-grade, non-malignant tumours diagnosed in adults, and 316 high-grade and 287 low-grade, non-malignant tumours diagnosed in children. High-grade tumours accounted for 86 percent of this burden. The burden of illness per tumour was £1.3 million for adults and £4.4 million for children. Premature mortality was the largest contributor to the overall burden, reflected in terms of health lost and future income lost. Conclusions The burden of illness of brain tumours in the UK is considerable and is largely driven by premature mortality and the associated loss in health and income. Interventions that extend life have the greatest potential to reduce the burden, including programmes to increase early diagnosis, or new innovative treatments.
Reference Key
openalex_W7204436477 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Clair Thorstensen-Woll, Marcus Cahill-Evans, Katie Murray, E. D. Greaves, Joe Goldbacher, Rob Malcolm, Matthew Taylor
Are you one of these authors? Claim your profile
Journal journal of neuro-oncology
Year 2026
DOI
10.1093/neuonc/noag172.016
URL
https://academic.oup.com/neuro-oncology/article-pdf/28/Supplement_1/noag172.016/70805905/noag172.016.pdf
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.